BRANFORD, Conn., Dec. 13 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. , a medical device company focused on innovative non- invasive vital signs monitoring, announced that its new cerebral oximeter, FORE-SIGHT, has been launched at the PostGraduate Assembly in Anesthesiology for the New York State Society of Anesthesiologists. The PGA, recognized worldwide as one of the most prestigious clinical meetings in anesthesiology, was held December 8-10 in New York City and showcased the latest technological advances in the field. The Company plans to have FORE-SIGHT monitoring systems available for sale starting in the first quarter of 2007.
The FORE-SIGHT Cerebral Oximeter measures absolute cerebral tissue oxygen saturation. These values are important to clinicians because cerebral hypoxia is one of the leading causes of brain injuries and occurs in many surgical and clinical situations. The patented, non-invasive FORE-SIGHT technology provides new, vital information that enables clinicians to identify and quickly respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.
"The unveiling of FORE-SIGHT at the PGA marks a significant milestone in the development of this unique product," stated Louis P. Scheps, President and CEO of CASMED. "We believe that the measurement of absolute brain oxygenation will become a standard of care, particularly in cardiovascular surgeries, high-risk general surgical procedures, and in critical care settings where there is strong potential for brain oxygen deprivation."
Andrew E. Kersey, Chief Operating Officer, continued, "The introduction of FORE-SIGHT at the PGA has generated significant interest from the medical community who recognize the need for non-invasive, absolute monitoring of oxygen saturation in the brain. We are proceeding on schedule with our plans to finalize the introduction of this product to the marketplace, and will complete comprehensive training of our clinical specialists and national distribution network in January."
About CAS Medical Systems, Inc. (CASMED(TM))
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, blood pressure cuffs, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For more information contact: ir@casmed.com Investors Media Financial Dynamics Financial Dynamics John Capodanno Robert Stanislaro 212-850-5705 212-850-5657 jcapodanno@fd-us.comrstanislaro@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company's most recent Form 10-KSB and other Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate," "believe," "estimate," "expect," "may," "objective," "plan," "possible," "potential," "project," "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward- looking statements, whether as a result of future events, new information or otherwise.
CAS Medical Systems, Inc.CONTACT: Investors - John Capodanno, +1-212-850-5705, jcapodanno@fd-us.com, Media - Robert Stanislaro, +1-212-850-5657, rstanislaro@fd-us.com,both of Financial Dynamics
Web site: http://www.casmed.com//
